
In the United States, lung cancer is the leading cause of death attributed to cancer, with long-standing and persistent racial and ethnic disparities in incidence and survival. Despite increased recognition of structural racism and its association with greater risk of developing chronic medical and mental health conditions among racial and ethnic minority groups, a gap remains in understanding how lung cancer risk may be impacted by structural racism.
According to Sidra N. Bonner, MD, MPH, and colleagues, it is important to investigate how structural racism—via polices, practices, unfair treatment, and oppression—creates inequitable population-level risks for lung cancer across racial and ethnic groups. Additionally, without consideration of structural racism and its association with lung cancer risk, the possibility to implement effective interventions to mitigate lung cancer risk is limited. Researchers conducted a scoping review of how structural racism contributes to differential population-level exposure to lung cancer risk factors across racial and ethnic groups. Their findings were reported in JAMA Oncology [published online November 30, 2023; doi:10.1001/jamaoncol.2023.4897].
For the scoping review, the researchers conducted a comprehensive search of the PubMed, Embase, and MedNar databases covering English-language studies published in the United States from January 1, 2010, through June 30, 2022. Exclusion criteria included if a study did not focus on lung cancer, did not include a domain of structural racism, or focused on lung cancer mortality and survival but not risk or lung cancer risk factors. The analysis included 22 studies focused on assessing structural domains associated with systemic racism. The key domains examined included housing and built environment, occupation and employment, health care, economic and educational opportunity, private industry, perceived stress and discrimination, and criminal justice involvement.